Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Lymphomas and Multiple Myeloma
NCT00112723Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Dec 2005
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in lymphoma, multiple myeloma (MM), sponsored by National Cancer Institute. Started Dec 2005; status: terminated.
02
Drugs
alvocidib
03
Conditions
lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT00112723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112723.